Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Stone

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Ebiomedicine|October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachBhargava Kandala, Nele Plock, Akshita Chawla, et al.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Biopharmaceutics & Drug Disposition|June 16, 2007
Dose-proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteersArthur Bergman, Goutam C Mistry, Wen-Lin Luo, et al.
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2016
The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal WomenStefan Zajic, Stefaan Rossenu, David Hreniuk, et al.
Healthcare (Basel, Switzerland)|November 6, 2019
Evaluating the Comparative Effectiveness of Two Diets in Pediatric Inflammatory Bowel Disease: A Study Protocol for a Series of N-of-1 TrialsHeather C Kaplan, Lisa Opipari-Arrigan, Christopher H Schmid, et al.
American Journal of Therapeutics|May 13, 2009
Pharmacokinetics of laropiprant and glucuronide metabolite in patients with severe renal insufficiencyMark Stroh, Larissa Wenning, Wen-Lin Luo, et al.
Clinical and Translational Science|July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisDaniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Journal of Clinical Pharmacology|February 9, 2008
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteersCarol Addy, Susie Li, Nancy Agrawal, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|June 25, 2003
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasmaDavid W Haas, Benjamin Johnson, Janet Nicotera, et al.
Ebiomedicine|October 1, 2022
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approachBhargava Kandala, Nele Plock, Akshita Chawla, et al.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Biopharmaceutics & Drug Disposition|June 16, 2007
Dose-proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteersArthur Bergman, Goutam C Mistry, Wen-Lin Luo, et al.
Clinical Pharmacology and Therapeutics|January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open DataDaniela J Conrado, Jackson Burton, Derek Hill, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 13, 2016
The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal WomenStefan Zajic, Stefaan Rossenu, David Hreniuk, et al.
Healthcare (Basel, Switzerland)|November 6, 2019
Evaluating the Comparative Effectiveness of Two Diets in Pediatric Inflammatory Bowel Disease: A Study Protocol for a Series of N-of-1 TrialsHeather C Kaplan, Lisa Opipari-Arrigan, Christopher H Schmid, et al.
American Journal of Therapeutics|May 13, 2009
Pharmacokinetics of laropiprant and glucuronide metabolite in patients with severe renal insufficiencyMark Stroh, Larissa Wenning, Wen-Lin Luo, et al.
Clinical and Translational Science|July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisDaniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Journal of Clinical Pharmacology|February 9, 2008
Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteersCarol Addy, Susie Li, Nancy Agrawal, et al.
Pageof 5